Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05294640 · ClinicalTrials.gov registry record · Phase 4
Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 95
- Enrollment target
NCT05294640: Completed Phase 4 study, sponsored by University of California, San Francisco.
NCT05294640 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 95 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05294640, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 95 participants
- Enrollment target
Study Summary
The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures
Primary Outcome
Pain on a scale of 0-10 during injection process (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after injection.
Interventions
- DRUG 0.9% Bacteriostatic Local Anesthetic Injection
- DRUG 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection
- PROCEDURE Eyelid Lesion Removal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-05-17 |
| Est. Completion | 2023-02-21 |
| Phase | Phase 4 |
What the finished NCT05294640 record still lists
NCT05294640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 3 interventions - of which 0.9% Bacteriostatic Local Anesthetic Injection is the first listed.
NCT05294640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05294640 about?
NCT05294640 is a clinical study titled "Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures". The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures
What is the current status of trial NCT05294640?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2022-05-17. Estimated completion is 2023-02-21.
What interventions are being tested in trial NCT05294640?
The interventions under investigation include: 0.9% Bacteriostatic Local Anesthetic Injection (DRUG), 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic Injection (DRUG), Eyelid Lesion Removal (PROCEDURE).
Who is sponsoring clinical trial NCT05294640?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05294640's enrollment target sits among peer trials
95 869th of 2000 higher than 1,130 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI